Stifel Nicolaus Forecasts Strong Price Appreciation for agilon health (NYSE:AGL) Stock

agilon health (NYSE:AGL) had its target price raised by Stifel Nicolaus from $2.00 to $3.00 in a note issued to investors on Wednesday,Benzinga reports. The firm currently has a “hold” rating on the stock. Stifel Nicolaus’ target price suggests a potential downside of 10.31% from the company’s previous close.

A number of other brokerages have also issued reports on AGL. TD Cowen decreased their target price on agilon health from $6.00 to $2.00 and set a “hold” rating on the stock in a research report on Monday, November 11th. Macquarie began coverage on shares of agilon health in a research report on Monday, December 16th. They issued a “neutral” rating and a $3.00 target price on the stock. Citigroup upgraded shares of agilon health from a “sell” rating to a “neutral” rating and upped their price target for the stock from $1.75 to $2.25 in a research report on Friday, January 10th. William Blair downgraded shares of agilon health from an “outperform” rating to a “market perform” rating in a research note on Friday, November 8th. Finally, Royal Bank of Canada reissued an “outperform” rating and set a $3.00 price objective on shares of agilon health in a research note on Tuesday, November 19th. Two research analysts have rated the stock with a sell rating, thirteen have issued a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $3.95.

agilon health Stock Performance

Shares of AGL stock opened at $3.35 on Wednesday. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06. agilon health has a 12-month low of $1.50 and a 12-month high of $7.73. The business’s 50 day moving average is $2.94 and its two-hundred day moving average is $3.04. The company has a market capitalization of $1.38 billion, a P/E ratio of -3.56 and a beta of 0.66.

Insider Transactions at agilon health

In related news, Director John William Wulf purchased 45,000 shares of the business’s stock in a transaction on Thursday, December 5th. The shares were bought at an average price of $2.18 per share, for a total transaction of $98,100.00. Following the acquisition, the director now directly owns 206,133 shares in the company, valued at $449,369.94. This trade represents a 27.93 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Karen Mcloughlin acquired 25,000 shares of the firm’s stock in a transaction dated Friday, December 13th. The stock was bought at an average price of $2.20 per share, with a total value of $55,000.00. Following the purchase, the director now directly owns 73,166 shares in the company, valued at approximately $160,965.20. This trade represents a 51.90 % increase in their position. The disclosure for this purchase can be found here. Over the last 90 days, insiders have purchased 77,500 shares of company stock valued at $169,600. 3.20% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. JPMorgan Chase & Co. lifted its position in shares of agilon health by 326.4% during the 3rd quarter. JPMorgan Chase & Co. now owns 1,415,419 shares of the company’s stock worth $5,563,000 after purchasing an additional 1,083,492 shares during the last quarter. Inspire Investing LLC raised its stake in agilon health by 106.6% in the fourth quarter. Inspire Investing LLC now owns 217,550 shares of the company’s stock valued at $413,000 after buying an additional 112,241 shares in the last quarter. Citigroup Inc. lifted its holdings in agilon health by 2,251.5% during the 3rd quarter. Citigroup Inc. now owns 2,028,246 shares of the company’s stock worth $7,971,000 after buying an additional 1,941,993 shares during the last quarter. Geode Capital Management LLC boosted its position in shares of agilon health by 1.2% during the 3rd quarter. Geode Capital Management LLC now owns 6,893,517 shares of the company’s stock worth $27,097,000 after acquiring an additional 84,889 shares in the last quarter. Finally, Empowered Funds LLC purchased a new position in shares of agilon health in the 4th quarter valued at about $97,000.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.